2Becouarn Y, Agostini C, Trufflandier N, et al. Oxaliplatin : available data in non-colorectal gastrointestinal malignancies [J]. Crit Rev Oncol Hematol,2001,40(3) :265.
3Coruss PM. Oxaliplatin in tumours other than colorectal cancer[ J]. Oncoloaw. 2000.14( Suool : 12) : 35.
4Louvet C, Andre T, Tigaud JM, et al. Phase Ⅱ study of oxaliplatin, fluorouracil,and folinic acid in locally advanced or metastatic gastic cancer patients [ J ]. Clin Oncol, 2002,20(23) : 4543.
5Maindratdt-Goebel F, Louet C, Andre T, et al. Oxliplatin added to the simplified bimonthly leucovorin and fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)[J]. Eur J cancer, 1999,35(9) : 1338.
6Casclnu S, Catalano V, Cordelia L. et al. Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer : a randomized, double-blind, placebo-controlled trial [ J ]. Clin cncol,2002.20(16) :3478.
7Raymond E, Buquet-Fagot C, Djellul S, et al. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon,breast and ovarian cancers [J].Anticancer Drugs,1997,8(9):876-885.
8De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18(16):2938-2947.
